3
15 was then achieved using BBr3 in DCM at -78 °C to rt in a
highly diluted condition after 24 h. The NMR spectrum of
synthetic racemic actinophenanthroline A exactly matches with
the reported actinophenanthroline A. Thus, we successfully
completed the total synthesis of racemic actinophenanthroline A.
natural product along with the synthetic product (see
Supporting Information).
In conclusion, we have successfully achieved the synthesis of
both enantiopure actinophenanthroline A as well as the racemic
version. The easier, classical and economical methods had been
utilized to synthesize this alkaloid. This synthetic strategy
administers an easier route to synthesize the other analogue
alkaloids.
Scheme 4. Synthesis of racemic Actinophenanthroline A
Acknowledgments
We thank DST for financial support. S.K.G. also thanks UGC
for senior research fellowship.
Supplementary Material
Experimental procedure, NMR, HRMS and Crystallographic data
are available in supporting information.
References and notes
1.
Nam, S- J.; Kauffman, C. A.; Jensen, P. R.; E. M. Curtis; Rheingold,
A. L.; Fenical W. Org. Lett. 2015, 17, 3240–3243.
After
a
successful synthetic execution of racemic
2.
3.
Skraup, H.; Vortmann, G. Monatsh. Chem. 1882, 3, 572.
actinophenanthroline A we diverted our focus again towards the
enantiopure actinophenanthroline A. Thus, we protected the
hydroxyl group of L-lactic acid with acetyl group which indeed
became an electron withdrawing group to α of the acid group.
(S)-2-acetoxypropanoic acid was prepared via three steps, where
the acid group was first protected with benzyl group using benzyl
bromide in basic condition. Next, the acetoxylation was achieved
using acetic anhydride with DMAP (cat.) followed by
deprotection of the benzyl group using hydrogenation led to the
(S)-2-acetoxypropanoic acid (see Supporting Information).
a) Felber, J. P.; Coombs, T. L.; Vallee, B. L. Biochemistry 1962, 1,
231−238. b) Salvesen, G. S.; Nagase, H. Proteolytic Enzymes: A
Practica Approach, 2nd ed.; Oxford University Press: Oxford, U.K.,
2001; 1, 105−130.
4.
5.
(a) Wang, S.; Hartley, D. P.; Ciccotto, S. L.; Vincent, S. H.; Franklin,
R. B.; Kim, M. S. Drug Metab. Dispos. 2003, 31, 773−775. (b) Carr,
B. A.; Franklin, M. R. J. Biochem. Mol. Toxicol. 1999, 13, 77−82. (c)
Carr, B. A.; Franklin, M. R. Xenobiotica 1998, 28, 949−956.
a) Yapi, A. D.; Mustof, M.; Chaviqnon, O.; Teulade, J. C.; Mallie, M.;
Chapat, J. P.; Blache, Y. Chem. Pharm. Bull. 2000, 48, 1886−1889. b)
Eqan, T. J.; Koch, K. R.; Swan, P. L.; Clarkson, C.; Van Schalkwyk,
D. A.; Smith, P. J. J. Med. Chem. 2004, 47, 2926−2934. c) Yapi, A.-
D.; Valentin, A.; Chezal, J.-M.; Chavignon, O.; Chaillot, B.; Gerhardt,
R.; Teulade, J.- C.; Blache, Y. Arch. Pharm. Chem. Life Sci. 2006,
339, 201−206.
Scheme 5. Synthesis of enantiospecific Actinophenanthroline
A
6.
7.
a) Sammes, P. G.; Yahioglu, G. Chem. Soc. Rev. 1994, 23, 327-334. b)
Brand, R. M.; Hannah, T. L. AAPS Pharmsci. 2000, 35, 1- 5. c) Song,
G.; Zhang, Y.; Su, Y.; Deng, W.; Han, K.; Li, X. Organometallics
2008, 27, 6193–6201.
a) Prakash K. S.; Nagarajan, R. Org. Lett. 2014, 16, 244–246. b)
Ramkumar, N.; Nagarajan, R. J. Org. Chem. 2013, 78, 2802–2807. c)
Ramesh, S.; Nagarajan, R. J. Org. Chem. 2013, 78, 545–558. d)
Ramkumar, N.; Nagarajan, R. J. Org. Chem. 2014, 79, 736–741. e)
Ghosh, S. K.; Nagarajan, R. RSC Adv. 2014, 4, 63147. f) Ghosh, S. K.;
Nagarajan, R. RSC Adv. 2016, 6, 27378.
8.
9.
a) Graf, G. I.; Hastreiter, D.; da Silva, E. L.; Rebelo, R. A.;
Montalbanb, A. G.; McKillopc, A. Tetrahedron 2002, 58, 9095–9100.
b) Symeonidis, T. S.; Lykakis, I. N.; Litinas, K. E. Tetrahedron, 2013,
1–69. d) Su, Q.; Li, P.; He, M.; Wu, Q.; Ye, L.; Mu, Y. Org. Lett.
2014, 16, 18−21. e) Panda, K.; Siddiqui, I.; Mahata, P. K.; Ila, H.;
Junjappa, H. Synlett 2004, 3, 0449–0452.
b) Choi, H. Y.; Srisook, E.; Jang, K. S.; Chi, D. Y. J. Org.
Chem. Heterocycl. Compd. 2006, 42, 701-718.
With desired acid in hand, we carried out the key coupling
reaction between the amine (7) and (S)-2-acetoxypropanoic acid
with EDCI. HCl in DCM. The reaction was very sluggish, after
72 h also it did not reach completion. Hence, we interrupted the
reaction and isolated the pure coupled product 19 along with
some unreacted starting amine (7). The cleavage of O-acetate
group of compound 19 was performed selectively using K2CO3 in
MeOH solvent at 0 °C, within 10 mins the reaction was
completed to give compound 20 in quantitative yields. On
treatment of compound 20 with BBr3 in DCM the deprotection of
methoxy group was achieved in 72 % yield to obtain the
enantiopure actinophenanthroline A. We accomplished the total
synthesis of racemic as well as enantiopure actinophenanthroline
A with overall 5.11% and 4.8% yields respectively. All spectral
data and HRMS data is consistent with the data of isolated
10. While compiling our manuscript the first synthesis of this alkaloid has
appeared in the following journal.
Garcia-Barrantes, P. M.; Harp, J. R.; Lindsley, C. W. Tetrahedron
Lett. 2016, 57, 2194–2196.
11. Nojiri, A.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2008, 130,
5630–5631.
12. Hongen, T.; Taniguchi, T.; Nomura, S.; Kadokawa, J.; Monde, K.
Macromolecules 2014, 47, 5313−5319.
13. Molecular formula: C15H15N3O, unit cell parameters: a 12.1928(9), b
12.9524(10), c 16.6378(13); CCDC 1445332.